A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/137 (2006.01) A61K 9/00 (2006.01) A61K 9/16 (2006.01) A61K 9/20 (2006.01) A61K 9/24 (2006.01) A61K 9/50 (2006.01) A61P 25/00 (2006.01)
Patent
CA 2515394
A pharmaceutical combination includes an effective amount for a day of amphetamine in base and/or salt form where the molar ratio of 1-amphetamine to d~amphetamine released therefrom in a time period later in the day is higher than said ratio released therefrom in a time period earlier in the day. The combination is used for the treatment of ADHD.
L'invention concerne une combinaison pharmaceutique comprenant une quantité suffisante pour 24 heures d'amphétamine sous forme de base et/ou de sel, le rapport molaire de la 1-amphétamine à la d-amphétamine à libération plus tardive dans la journée étant supérieur au rapport libéré plus tôt dans la journée. Cette combinaison est utile dans le traitement de l'ADHD.
Couch Richard A.
Hodgkins Paul
Michaels Alex
Gowling Lafleur Henderson Llp
Shire Biochem Inc.
Shire Canada Inc.
LandOfFree
Enantiomeric amphetamine compositions for the treatment of adhd does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enantiomeric amphetamine compositions for the treatment of adhd, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enantiomeric amphetamine compositions for the treatment of adhd will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1551442